Global Tuberculosis Vaccination Market Research Report 2024(Status and Outlook)
Report Overview
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
The global Tuberculosis Vaccination market size was estimated at USD 76 million in 2023 and is projected to reach USD 93.47 million by 2030, exhibiting a CAGR of 3.00% during the forecast period.
North America Tuberculosis Vaccination market size was USD 19.80 million in 2023, at a CAGR of 2.57% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Tuberculosis Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Vaccination market in any manner.
Global Tuberculosis Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
The global Tuberculosis Vaccination market size was estimated at USD 76 million in 2023 and is projected to reach USD 93.47 million by 2030, exhibiting a CAGR of 3.00% during the forecast period.
North America Tuberculosis Vaccination market size was USD 19.80 million in 2023, at a CAGR of 2.57% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Tuberculosis Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Vaccination market in any manner.
Global Tuberculosis Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tuberculosis Vaccination Market
- Overview of the regional outlook of the Tuberculosis Vaccination Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tuberculosis Vaccination
1.2 Key Market Segments
1.2.1 Tuberculosis Vaccination Segment by Type
1.2.2 Tuberculosis Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Vaccination Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tuberculosis Vaccination Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Tuberculosis Vaccination Sales by Manufacturers (2019-2024)
3.2 Global Tuberculosis Vaccination Revenue Market Share by Manufacturers (2019-2024)
3.3 Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tuberculosis Vaccination Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tuberculosis Vaccination Sales Sites, Area Served, Product Type
3.6 Tuberculosis Vaccination Market Competitive Situation and Trends
3.6.1 Tuberculosis Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tuberculosis Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUBERCULOSIS VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Vaccination Sales Market Share by Type (2019-2024)
6.3 Global Tuberculosis Vaccination Market Size Market Share by Type (2019-2024)
6.4 Global Tuberculosis Vaccination Price by Type (2019-2024)
7 TUBERCULOSIS VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Vaccination Market Sales by Application (2019-2024)
7.3 Global Tuberculosis Vaccination Market Size (M USD) by Application (2019-2024)
7.4 Global Tuberculosis Vaccination Sales Growth Rate by Application (2019-2024)
8 TUBERCULOSIS VACCINATION MARKET SEGMENTATION BY REGION
8.1 Global Tuberculosis Vaccination Sales by Region
8.1.1 Global Tuberculosis Vaccination Sales by Region
8.1.2 Global Tuberculosis Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Tuberculosis Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tuberculosis Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tuberculosis Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tuberculosis Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tuberculosis Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Tuberculosis Vaccination Basic Information
9.1.2 Merck Tuberculosis Vaccination Product Overview
9.1.3 Merck Tuberculosis Vaccination Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Tuberculosis Vaccination SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Japan BCG Lab
9.2.1 Japan BCG Lab Tuberculosis Vaccination Basic Information
9.2.2 Japan BCG Lab Tuberculosis Vaccination Product Overview
9.2.3 Japan BCG Lab Tuberculosis Vaccination Product Market Performance
9.2.4 Japan BCG Lab Business Overview
9.2.5 Japan BCG Lab Tuberculosis Vaccination SWOT Analysis
9.2.6 Japan BCG Lab Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India Tuberculosis Vaccination Basic Information
9.3.2 Serum Institute of India Tuberculosis Vaccination Product Overview
9.3.3 Serum Institute of India Tuberculosis Vaccination Product Market Performance
9.3.4 Serum Institute of India Tuberculosis Vaccination SWOT Analysis
9.3.5 Serum Institute of India Business Overview
9.3.6 Serum Institute of India Recent Developments
9.4 AJ Vaccines
9.4.1 AJ Vaccines Tuberculosis Vaccination Basic Information
9.4.2 AJ Vaccines Tuberculosis Vaccination Product Overview
9.4.3 AJ Vaccines Tuberculosis Vaccination Product Market Performance
9.4.4 AJ Vaccines Business Overview
9.4.5 AJ Vaccines Recent Developments
9.5 BioFarma
9.5.1 BioFarma Tuberculosis Vaccination Basic Information
9.5.2 BioFarma Tuberculosis Vaccination Product Overview
9.5.3 BioFarma Tuberculosis Vaccination Product Market Performance
9.5.4 BioFarma Business Overview
9.5.5 BioFarma Recent Developments
9.6 GreenSignal Bio Pharma
9.6.1 GreenSignal Bio Pharma Tuberculosis Vaccination Basic Information
9.6.2 GreenSignal Bio Pharma Tuberculosis Vaccination Product Overview
9.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Product Market Performance
9.6.4 GreenSignal Bio Pharma Business Overview
9.6.5 GreenSignal Bio Pharma Recent Developments
9.7 China National Biotec
9.7.1 China National Biotec Tuberculosis Vaccination Basic Information
9.7.2 China National Biotec Tuberculosis Vaccination Product Overview
9.7.3 China National Biotec Tuberculosis Vaccination Product Market Performance
9.7.4 China National Biotec Business Overview
9.7.5 China National Biotec Recent Developments
9.8 Biomed Lublin
9.8.1 Biomed Lublin Tuberculosis Vaccination Basic Information
9.8.2 Biomed Lublin Tuberculosis Vaccination Product Overview
9.8.3 Biomed Lublin Tuberculosis Vaccination Product Market Performance
9.8.4 Biomed Lublin Business Overview
9.8.5 Biomed Lublin Recent Developments
9.9 Taj Pharmaceuticals
9.9.1 Taj Pharmaceuticals Tuberculosis Vaccination Basic Information
9.9.2 Taj Pharmaceuticals Tuberculosis Vaccination Product Overview
9.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Product Market Performance
9.9.4 Taj Pharmaceuticals Business Overview
9.9.5 Taj Pharmaceuticals Recent Developments
9.10 Ataulpho de Paiva
9.10.1 Ataulpho de Paiva Tuberculosis Vaccination Basic Information
9.10.2 Ataulpho de Paiva Tuberculosis Vaccination Product Overview
9.10.3 Ataulpho de Paiva Tuberculosis Vaccination Product Market Performance
9.10.4 Ataulpho de Paiva Business Overview
9.10.5 Ataulpho de Paiva Recent Developments
9.11 IVAC – Institute of Vaccines and Medical Biologicals
9.11.1 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Basic Information
9.11.2 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Overview
9.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Market Performance
9.11.4 IVAC – Institute of Vaccines and Medical Biologicals Business Overview
9.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
9.12 Queen Saovabha Mem. Inst
9.12.1 Queen Saovabha Mem. Inst Tuberculosis Vaccination Basic Information
9.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Overview
9.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Market Performance
9.12.4 Queen Saovabha Mem. Inst Business Overview
9.12.5 Queen Saovabha Mem. Inst Recent Developments
9.13 Microgen
9.13.1 Microgen Tuberculosis Vaccination Basic Information
9.13.2 Microgen Tuberculosis Vaccination Product Overview
9.13.3 Microgen Tuberculosis Vaccination Product Market Performance
9.13.4 Microgen Business Overview
9.13.5 Microgen Recent Developments
10 TUBERCULOSIS VACCINATION MARKET FORECAST BY REGION
10.1 Global Tuberculosis Vaccination Market Size Forecast
10.2 Global Tuberculosis Vaccination Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tuberculosis Vaccination Market Size Forecast by Country
10.2.3 Asia Pacific Tuberculosis Vaccination Market Size Forecast by Region
10.2.4 South America Tuberculosis Vaccination Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tuberculosis Vaccination by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tuberculosis Vaccination Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tuberculosis Vaccination by Type (2025-2030)
11.1.2 Global Tuberculosis Vaccination Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tuberculosis Vaccination by Type (2025-2030)
11.2 Global Tuberculosis Vaccination Market Forecast by Application (2025-2030)
11.2.1 Global Tuberculosis Vaccination Sales (Kilotons) Forecast by Application
11.2.2 Global Tuberculosis Vaccination Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tuberculosis Vaccination
1.2 Key Market Segments
1.2.1 Tuberculosis Vaccination Segment by Type
1.2.2 Tuberculosis Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Vaccination Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tuberculosis Vaccination Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Tuberculosis Vaccination Sales by Manufacturers (2019-2024)
3.2 Global Tuberculosis Vaccination Revenue Market Share by Manufacturers (2019-2024)
3.3 Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tuberculosis Vaccination Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tuberculosis Vaccination Sales Sites, Area Served, Product Type
3.6 Tuberculosis Vaccination Market Competitive Situation and Trends
3.6.1 Tuberculosis Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tuberculosis Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUBERCULOSIS VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Vaccination Sales Market Share by Type (2019-2024)
6.3 Global Tuberculosis Vaccination Market Size Market Share by Type (2019-2024)
6.4 Global Tuberculosis Vaccination Price by Type (2019-2024)
7 TUBERCULOSIS VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Vaccination Market Sales by Application (2019-2024)
7.3 Global Tuberculosis Vaccination Market Size (M USD) by Application (2019-2024)
7.4 Global Tuberculosis Vaccination Sales Growth Rate by Application (2019-2024)
8 TUBERCULOSIS VACCINATION MARKET SEGMENTATION BY REGION
8.1 Global Tuberculosis Vaccination Sales by Region
8.1.1 Global Tuberculosis Vaccination Sales by Region
8.1.2 Global Tuberculosis Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Tuberculosis Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tuberculosis Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tuberculosis Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tuberculosis Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tuberculosis Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Tuberculosis Vaccination Basic Information
9.1.2 Merck Tuberculosis Vaccination Product Overview
9.1.3 Merck Tuberculosis Vaccination Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Tuberculosis Vaccination SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Japan BCG Lab
9.2.1 Japan BCG Lab Tuberculosis Vaccination Basic Information
9.2.2 Japan BCG Lab Tuberculosis Vaccination Product Overview
9.2.3 Japan BCG Lab Tuberculosis Vaccination Product Market Performance
9.2.4 Japan BCG Lab Business Overview
9.2.5 Japan BCG Lab Tuberculosis Vaccination SWOT Analysis
9.2.6 Japan BCG Lab Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India Tuberculosis Vaccination Basic Information
9.3.2 Serum Institute of India Tuberculosis Vaccination Product Overview
9.3.3 Serum Institute of India Tuberculosis Vaccination Product Market Performance
9.3.4 Serum Institute of India Tuberculosis Vaccination SWOT Analysis
9.3.5 Serum Institute of India Business Overview
9.3.6 Serum Institute of India Recent Developments
9.4 AJ Vaccines
9.4.1 AJ Vaccines Tuberculosis Vaccination Basic Information
9.4.2 AJ Vaccines Tuberculosis Vaccination Product Overview
9.4.3 AJ Vaccines Tuberculosis Vaccination Product Market Performance
9.4.4 AJ Vaccines Business Overview
9.4.5 AJ Vaccines Recent Developments
9.5 BioFarma
9.5.1 BioFarma Tuberculosis Vaccination Basic Information
9.5.2 BioFarma Tuberculosis Vaccination Product Overview
9.5.3 BioFarma Tuberculosis Vaccination Product Market Performance
9.5.4 BioFarma Business Overview
9.5.5 BioFarma Recent Developments
9.6 GreenSignal Bio Pharma
9.6.1 GreenSignal Bio Pharma Tuberculosis Vaccination Basic Information
9.6.2 GreenSignal Bio Pharma Tuberculosis Vaccination Product Overview
9.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Product Market Performance
9.6.4 GreenSignal Bio Pharma Business Overview
9.6.5 GreenSignal Bio Pharma Recent Developments
9.7 China National Biotec
9.7.1 China National Biotec Tuberculosis Vaccination Basic Information
9.7.2 China National Biotec Tuberculosis Vaccination Product Overview
9.7.3 China National Biotec Tuberculosis Vaccination Product Market Performance
9.7.4 China National Biotec Business Overview
9.7.5 China National Biotec Recent Developments
9.8 Biomed Lublin
9.8.1 Biomed Lublin Tuberculosis Vaccination Basic Information
9.8.2 Biomed Lublin Tuberculosis Vaccination Product Overview
9.8.3 Biomed Lublin Tuberculosis Vaccination Product Market Performance
9.8.4 Biomed Lublin Business Overview
9.8.5 Biomed Lublin Recent Developments
9.9 Taj Pharmaceuticals
9.9.1 Taj Pharmaceuticals Tuberculosis Vaccination Basic Information
9.9.2 Taj Pharmaceuticals Tuberculosis Vaccination Product Overview
9.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Product Market Performance
9.9.4 Taj Pharmaceuticals Business Overview
9.9.5 Taj Pharmaceuticals Recent Developments
9.10 Ataulpho de Paiva
9.10.1 Ataulpho de Paiva Tuberculosis Vaccination Basic Information
9.10.2 Ataulpho de Paiva Tuberculosis Vaccination Product Overview
9.10.3 Ataulpho de Paiva Tuberculosis Vaccination Product Market Performance
9.10.4 Ataulpho de Paiva Business Overview
9.10.5 Ataulpho de Paiva Recent Developments
9.11 IVAC – Institute of Vaccines and Medical Biologicals
9.11.1 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Basic Information
9.11.2 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Overview
9.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Market Performance
9.11.4 IVAC – Institute of Vaccines and Medical Biologicals Business Overview
9.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
9.12 Queen Saovabha Mem. Inst
9.12.1 Queen Saovabha Mem. Inst Tuberculosis Vaccination Basic Information
9.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Overview
9.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Market Performance
9.12.4 Queen Saovabha Mem. Inst Business Overview
9.12.5 Queen Saovabha Mem. Inst Recent Developments
9.13 Microgen
9.13.1 Microgen Tuberculosis Vaccination Basic Information
9.13.2 Microgen Tuberculosis Vaccination Product Overview
9.13.3 Microgen Tuberculosis Vaccination Product Market Performance
9.13.4 Microgen Business Overview
9.13.5 Microgen Recent Developments
10 TUBERCULOSIS VACCINATION MARKET FORECAST BY REGION
10.1 Global Tuberculosis Vaccination Market Size Forecast
10.2 Global Tuberculosis Vaccination Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tuberculosis Vaccination Market Size Forecast by Country
10.2.3 Asia Pacific Tuberculosis Vaccination Market Size Forecast by Region
10.2.4 South America Tuberculosis Vaccination Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tuberculosis Vaccination by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tuberculosis Vaccination Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tuberculosis Vaccination by Type (2025-2030)
11.1.2 Global Tuberculosis Vaccination Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tuberculosis Vaccination by Type (2025-2030)
11.2 Global Tuberculosis Vaccination Market Forecast by Application (2025-2030)
11.2.1 Global Tuberculosis Vaccination Sales (Kilotons) Forecast by Application
11.2.2 Global Tuberculosis Vaccination Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Vaccination Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Vaccination Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tuberculosis Vaccination Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccination as of 2022)
Table 10. Global Market Tuberculosis Vaccination Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tuberculosis Vaccination Sales Sites and Area Served
Table 12. Manufacturers Tuberculosis Vaccination Product Type
Table 13. Global Tuberculosis Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tuberculosis Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Vaccination Market Challenges
Table 22. Global Tuberculosis Vaccination Sales by Type (Kilotons)
Table 23. Global Tuberculosis Vaccination Market Size by Type (M USD)
Table 24. Global Tuberculosis Vaccination Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tuberculosis Vaccination Sales Market Share by Type (2019-2024)
Table 26. Global Tuberculosis Vaccination Market Size (M USD) by Type (2019-2024)
Table 27. Global Tuberculosis Vaccination Market Size Share by Type (2019-2024)
Table 28. Global Tuberculosis Vaccination Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tuberculosis Vaccination Sales (Kilotons) by Application
Table 30. Global Tuberculosis Vaccination Market Size by Application
Table 31. Global Tuberculosis Vaccination Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tuberculosis Vaccination Sales Market Share by Application (2019-2024)
Table 33. Global Tuberculosis Vaccination Sales by Application (2019-2024) & (M USD)
Table 34. Global Tuberculosis Vaccination Market Share by Application (2019-2024)
Table 35. Global Tuberculosis Vaccination Sales Growth Rate by Application (2019-2024)
Table 36. Global Tuberculosis Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tuberculosis Vaccination Sales Market Share by Region (2019-2024)
Table 38. North America Tuberculosis Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tuberculosis Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tuberculosis Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tuberculosis Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tuberculosis Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Tuberculosis Vaccination Basic Information
Table 44. Merck Tuberculosis Vaccination Product Overview
Table 45. Merck Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Tuberculosis Vaccination SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Japan BCG Lab Tuberculosis Vaccination Basic Information
Table 50. Japan BCG Lab Tuberculosis Vaccination Product Overview
Table 51. Japan BCG Lab Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Japan BCG Lab Business Overview
Table 53. Japan BCG Lab Tuberculosis Vaccination SWOT Analysis
Table 54. Japan BCG Lab Recent Developments
Table 55. Serum Institute of India Tuberculosis Vaccination Basic Information
Table 56. Serum Institute of India Tuberculosis Vaccination Product Overview
Table 57. Serum Institute of India Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Serum Institute of India Tuberculosis Vaccination SWOT Analysis
Table 59. Serum Institute of India Business Overview
Table 60. Serum Institute of India Recent Developments
Table 61. AJ Vaccines Tuberculosis Vaccination Basic Information
Table 62. AJ Vaccines Tuberculosis Vaccination Product Overview
Table 63. AJ Vaccines Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AJ Vaccines Business Overview
Table 65. AJ Vaccines Recent Developments
Table 66. BioFarma Tuberculosis Vaccination Basic Information
Table 67. BioFarma Tuberculosis Vaccination Product Overview
Table 68. BioFarma Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. BioFarma Business Overview
Table 70. BioFarma Recent Developments
Table 71. GreenSignal Bio Pharma Tuberculosis Vaccination Basic Information
Table 72. GreenSignal Bio Pharma Tuberculosis Vaccination Product Overview
Table 73. GreenSignal Bio Pharma Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GreenSignal Bio Pharma Business Overview
Table 75. GreenSignal Bio Pharma Recent Developments
Table 76. China National Biotec Tuberculosis Vaccination Basic Information
Table 77. China National Biotec Tuberculosis Vaccination Product Overview
Table 78. China National Biotec Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. China National Biotec Business Overview
Table 80. China National Biotec Recent Developments
Table 81. Biomed Lublin Tuberculosis Vaccination Basic Information
Table 82. Biomed Lublin Tuberculosis Vaccination Product Overview
Table 83. Biomed Lublin Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Biomed Lublin Business Overview
Table 85. Biomed Lublin Recent Developments
Table 86. Taj Pharmaceuticals Tuberculosis Vaccination Basic Information
Table 87. Taj Pharmaceuticals Tuberculosis Vaccination Product Overview
Table 88. Taj Pharmaceuticals Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Taj Pharmaceuticals Business Overview
Table 90. Taj Pharmaceuticals Recent Developments
Table 91. Ataulpho de Paiva Tuberculosis Vaccination Basic Information
Table 92. Ataulpho de Paiva Tuberculosis Vaccination Product Overview
Table 93. Ataulpho de Paiva Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Ataulpho de Paiva Business Overview
Table 95. Ataulpho de Paiva Recent Developments
Table 96. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Basic Information
Table 97. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Overview
Table 98. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. IVAC – Institute of Vaccines and Medical Biologicals Business Overview
Table 100. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
Table 101. Queen Saovabha Mem. Inst Tuberculosis Vaccination Basic Information
Table 102. Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Overview
Table 103. Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Queen Saovabha Mem. Inst Business Overview
Table 105. Queen Saovabha Mem. Inst Recent Developments
Table 106. Microgen Tuberculosis Vaccination Basic Information
Table 107. Microgen Tuberculosis Vaccination Product Overview
Table 108. Microgen Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Microgen Business Overview
Table 110. Microgen Recent Developments
Table 111. Global Tuberculosis Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Tuberculosis Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Tuberculosis Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Tuberculosis Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Tuberculosis Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Tuberculosis Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Tuberculosis Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Tuberculosis Vaccination Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Tuberculosis Vaccination Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Tuberculosis Vaccination Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Tuberculosis Vaccination Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Tuberculosis Vaccination Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Tuberculosis Vaccination Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Vaccination Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Vaccination Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tuberculosis Vaccination Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccination as of 2022)
Table 10. Global Market Tuberculosis Vaccination Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tuberculosis Vaccination Sales Sites and Area Served
Table 12. Manufacturers Tuberculosis Vaccination Product Type
Table 13. Global Tuberculosis Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tuberculosis Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Vaccination Market Challenges
Table 22. Global Tuberculosis Vaccination Sales by Type (Kilotons)
Table 23. Global Tuberculosis Vaccination Market Size by Type (M USD)
Table 24. Global Tuberculosis Vaccination Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tuberculosis Vaccination Sales Market Share by Type (2019-2024)
Table 26. Global Tuberculosis Vaccination Market Size (M USD) by Type (2019-2024)
Table 27. Global Tuberculosis Vaccination Market Size Share by Type (2019-2024)
Table 28. Global Tuberculosis Vaccination Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tuberculosis Vaccination Sales (Kilotons) by Application
Table 30. Global Tuberculosis Vaccination Market Size by Application
Table 31. Global Tuberculosis Vaccination Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tuberculosis Vaccination Sales Market Share by Application (2019-2024)
Table 33. Global Tuberculosis Vaccination Sales by Application (2019-2024) & (M USD)
Table 34. Global Tuberculosis Vaccination Market Share by Application (2019-2024)
Table 35. Global Tuberculosis Vaccination Sales Growth Rate by Application (2019-2024)
Table 36. Global Tuberculosis Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tuberculosis Vaccination Sales Market Share by Region (2019-2024)
Table 38. North America Tuberculosis Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tuberculosis Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tuberculosis Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tuberculosis Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tuberculosis Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Tuberculosis Vaccination Basic Information
Table 44. Merck Tuberculosis Vaccination Product Overview
Table 45. Merck Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Tuberculosis Vaccination SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Japan BCG Lab Tuberculosis Vaccination Basic Information
Table 50. Japan BCG Lab Tuberculosis Vaccination Product Overview
Table 51. Japan BCG Lab Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Japan BCG Lab Business Overview
Table 53. Japan BCG Lab Tuberculosis Vaccination SWOT Analysis
Table 54. Japan BCG Lab Recent Developments
Table 55. Serum Institute of India Tuberculosis Vaccination Basic Information
Table 56. Serum Institute of India Tuberculosis Vaccination Product Overview
Table 57. Serum Institute of India Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Serum Institute of India Tuberculosis Vaccination SWOT Analysis
Table 59. Serum Institute of India Business Overview
Table 60. Serum Institute of India Recent Developments
Table 61. AJ Vaccines Tuberculosis Vaccination Basic Information
Table 62. AJ Vaccines Tuberculosis Vaccination Product Overview
Table 63. AJ Vaccines Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AJ Vaccines Business Overview
Table 65. AJ Vaccines Recent Developments
Table 66. BioFarma Tuberculosis Vaccination Basic Information
Table 67. BioFarma Tuberculosis Vaccination Product Overview
Table 68. BioFarma Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. BioFarma Business Overview
Table 70. BioFarma Recent Developments
Table 71. GreenSignal Bio Pharma Tuberculosis Vaccination Basic Information
Table 72. GreenSignal Bio Pharma Tuberculosis Vaccination Product Overview
Table 73. GreenSignal Bio Pharma Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GreenSignal Bio Pharma Business Overview
Table 75. GreenSignal Bio Pharma Recent Developments
Table 76. China National Biotec Tuberculosis Vaccination Basic Information
Table 77. China National Biotec Tuberculosis Vaccination Product Overview
Table 78. China National Biotec Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. China National Biotec Business Overview
Table 80. China National Biotec Recent Developments
Table 81. Biomed Lublin Tuberculosis Vaccination Basic Information
Table 82. Biomed Lublin Tuberculosis Vaccination Product Overview
Table 83. Biomed Lublin Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Biomed Lublin Business Overview
Table 85. Biomed Lublin Recent Developments
Table 86. Taj Pharmaceuticals Tuberculosis Vaccination Basic Information
Table 87. Taj Pharmaceuticals Tuberculosis Vaccination Product Overview
Table 88. Taj Pharmaceuticals Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Taj Pharmaceuticals Business Overview
Table 90. Taj Pharmaceuticals Recent Developments
Table 91. Ataulpho de Paiva Tuberculosis Vaccination Basic Information
Table 92. Ataulpho de Paiva Tuberculosis Vaccination Product Overview
Table 93. Ataulpho de Paiva Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Ataulpho de Paiva Business Overview
Table 95. Ataulpho de Paiva Recent Developments
Table 96. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Basic Information
Table 97. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Overview
Table 98. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. IVAC – Institute of Vaccines and Medical Biologicals Business Overview
Table 100. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
Table 101. Queen Saovabha Mem. Inst Tuberculosis Vaccination Basic Information
Table 102. Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Overview
Table 103. Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Queen Saovabha Mem. Inst Business Overview
Table 105. Queen Saovabha Mem. Inst Recent Developments
Table 106. Microgen Tuberculosis Vaccination Basic Information
Table 107. Microgen Tuberculosis Vaccination Product Overview
Table 108. Microgen Tuberculosis Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Microgen Business Overview
Table 110. Microgen Recent Developments
Table 111. Global Tuberculosis Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Tuberculosis Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Tuberculosis Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Tuberculosis Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Tuberculosis Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Tuberculosis Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Tuberculosis Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Tuberculosis Vaccination Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Tuberculosis Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Tuberculosis Vaccination Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Tuberculosis Vaccination Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Tuberculosis Vaccination Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Tuberculosis Vaccination Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Tuberculosis Vaccination Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tuberculosis Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Vaccination Market Size (M USD), 2019-2030
Figure 5. Global Tuberculosis Vaccination Market Size (M USD) (2019-2030)
Figure 6. Global Tuberculosis Vaccination Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Vaccination Market Size by Country (M USD)
Figure 11. Tuberculosis Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Tuberculosis Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tuberculosis Vaccination Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tuberculosis Vaccination Market Share by Type
Figure 18. Sales Market Share of Tuberculosis Vaccination by Type (2019-2024)
Figure 19. Sales Market Share of Tuberculosis Vaccination by Type in 2023
Figure 20. Market Size Share of Tuberculosis Vaccination by Type (2019-2024)
Figure 21. Market Size Market Share of Tuberculosis Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tuberculosis Vaccination Market Share by Application
Figure 24. Global Tuberculosis Vaccination Sales Market Share by Application (2019-2024)
Figure 25. Global Tuberculosis Vaccination Sales Market Share by Application in 2023
Figure 26. Global Tuberculosis Vaccination Market Share by Application (2019-2024)
Figure 27. Global Tuberculosis Vaccination Market Share by Application in 2023
Figure 28. Global Tuberculosis Vaccination Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tuberculosis Vaccination Sales Market Share by Region (2019-2024)
Figure 30. North America Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tuberculosis Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tuberculosis Vaccination Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tuberculosis Vaccination Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tuberculosis Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tuberculosis Vaccination Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tuberculosis Vaccination Sales Market Share by Region in 2023
Figure 44. China Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tuberculosis Vaccination Sales and Growth Rate (Kilotons)
Figure 50. South America Tuberculosis Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tuberculosis Vaccination Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tuberculosis Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tuberculosis Vaccination Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tuberculosis Vaccination Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tuberculosis Vaccination Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tuberculosis Vaccination Market Share Forecast by Type (2025-2030)
Figure 65. Global Tuberculosis Vaccination Sales Forecast by Application (2025-2030)
Figure 66. Global Tuberculosis Vaccination Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Tuberculosis Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Vaccination Market Size (M USD), 2019-2030
Figure 5. Global Tuberculosis Vaccination Market Size (M USD) (2019-2030)
Figure 6. Global Tuberculosis Vaccination Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Vaccination Market Size by Country (M USD)
Figure 11. Tuberculosis Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Tuberculosis Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tuberculosis Vaccination Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tuberculosis Vaccination Market Share by Type
Figure 18. Sales Market Share of Tuberculosis Vaccination by Type (2019-2024)
Figure 19. Sales Market Share of Tuberculosis Vaccination by Type in 2023
Figure 20. Market Size Share of Tuberculosis Vaccination by Type (2019-2024)
Figure 21. Market Size Market Share of Tuberculosis Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tuberculosis Vaccination Market Share by Application
Figure 24. Global Tuberculosis Vaccination Sales Market Share by Application (2019-2024)
Figure 25. Global Tuberculosis Vaccination Sales Market Share by Application in 2023
Figure 26. Global Tuberculosis Vaccination Market Share by Application (2019-2024)
Figure 27. Global Tuberculosis Vaccination Market Share by Application in 2023
Figure 28. Global Tuberculosis Vaccination Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tuberculosis Vaccination Sales Market Share by Region (2019-2024)
Figure 30. North America Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tuberculosis Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tuberculosis Vaccination Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tuberculosis Vaccination Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tuberculosis Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tuberculosis Vaccination Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tuberculosis Vaccination Sales Market Share by Region in 2023
Figure 44. China Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tuberculosis Vaccination Sales and Growth Rate (Kilotons)
Figure 50. South America Tuberculosis Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tuberculosis Vaccination Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tuberculosis Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tuberculosis Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tuberculosis Vaccination Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tuberculosis Vaccination Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tuberculosis Vaccination Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tuberculosis Vaccination Market Share Forecast by Type (2025-2030)
Figure 65. Global Tuberculosis Vaccination Sales Forecast by Application (2025-2030)
Figure 66. Global Tuberculosis Vaccination Market Share Forecast by Application (2025-2030)
